Skip to main content

Table 4 Summarization of DE results for multiple time point comparisons of octreotide treated vs untreated GH3 cells (p-adjusted < 0.05)

From: Transcriptome of GH-producing pituitary neuroendocrine tumours and models are significantly affected by somatostatin analogues

Comparison

Count of DEG’s

Count of DEG’s (upregulated)

Count of DEG’s (downregulated)

Median L2FC upregulated (IQR)

Median L2FC downregulated (IQR)

4 h vs control

6

4 (66%)

2 (33%)

0.54 (0.49)

− 0.48 (0.05)

8 h vs control

10

8 (80%)

2 (20%)

4.63 (12.35)

− 1.12 (0.63)

24 h vs control

23

14 (61%)

9 (39%)

8.95 (13.72)

− 0.27 (0.08)

  1. DE differential expression